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Abstract: Adjuvant chemotherapy and steroid therapy have been demonstrated to interfere with the wound
healing process. The aim of this study was to evaluate the effects of 5-fluorouracil, interferon, and dexametha-
sone, on the healing of colon anastomosis by assessing morphometric and fractal parameters of the colonic wall.
An experimental anastomosis of the ascending colon was performed in 60 male Wistar rats, which were then
randomly assigned to four groups. On the second to sixth post-operative days, the rats were administered
5-fluorouracil, interferon-a, dexamethasone, or 0.9% NaCl solution as a control. Macroscopic, histomorphometric
and microbiological evaluation was performed in order to assess healing of the anastomosis. In three animals
from the dexamethasone group, there was leakage of anastomosis; adhesion formation was highest in the inter-
feron group, and significantly higher than in the control and 5-fluorouracil groups. Histomorphometric param-
eter alterations were most pronounced on the seventh and fourteenth post-operative days in all treatment groups,
with submucosal thickness the most affected parameter. Connective tissue fractal dimension was significantly
decreased in those animals treated with interferon and dexamethasone. All three pharmaceutical agents im-
paired healing of anastomosis, and promoted infection in the anastomosis and skin wound sites. As dexametha-
sone induced both morphometric and macroscopic alterations, it was considered the most detrimental in this
study. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 1, pp. 80–89)
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Introduction
The management of patients suffering from gas-
trointestinal neoplasms usually requires surgical re-
section followed by adjuvant chemotherapy. Patients
operated upon due to advanced bowel inflammation
need a follow-up comprising the administration of
systemic steroids [1, 2]. Both treatments have been
found to have local and systemic adverse effects
[3–6]. Since its introduction, 5-fluorouracil has been
considered the gold standard therapy for colorectal
cancer. It can be administered alone, or in combina-
tion with other pharmaceutical agents, including in-
terferon or the newly-developed cisplatin derivative
oxaliplatin [7–10].
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It has been demonstrated that surgery itself stim-
ulates the development of micrometastases and pro-
motes cell proliferation in already existing metastatic
sites [11, 12].
Therefore, early or immediate implementation of
adjuvant chemotherapy seems to be beneficial in
terms of residual disease, liver metastases and recur-
rence prevention, and has been demonstrated to im-
prove disease outcomes [13, 14]. The literature de-
scribing the effects of chemotherapeutics on the heal-
ing process is not wholly consistent, but several stu-
dies have reported the deleterious influence of
5-fluorouracil on the integrity of intestinal anastomo-
sis. Post-operative complications have been shown to
have a negative impact on long-term outcomes, and
enteroanastomosis dehiscence has been observed to
worsen prognosis in colorectal cancer patients [15,
16]. Thus, despite its obvious efficacy in tumor treat-
ment, adjuvant therapy is usually postponed until the
wound healing process is complete.
Some of the adverse effects of 5-fluorouracil may
result from the down-regulation of collagen synthesis,
as well as from suppression of local defense mecha-
nisms in the site of anastomosis [17–19]. A similar
influence has been attributed to steroid therapy. Sys-
temic steroids have been demonstrated in rat experi-
mental models to inhibit angiogenesis and the syn-
thesis of collagen, to stabilize lysosomal membranes
of the leukocytes, and to impede migration of proin-
flammatory cells [20–22]. Alterations of systemic and
local immunity responses evoked by steroid intake
may promote the development of pathogenic bacte-
rial flora, something which further slows the healing
process [18, 23]. Even if properly treated, infections
may contribute to anastomosis and abdominal wound
dehiscence, scar overgrowth and subsequent incisional
hernia, requiring additional surgical intervention [24].
Most of the studies which have evaluated the in-
fluence of chemotherapeutic and steroid agents on
colonic anastomosis healing have concentrated on
bursting pressures and collagen content analysis with
standard histological methods [25, 26].
Our study aimed to evaluate the effects of 5-fluo-
rouracil, interferon, and dexamethasone on the heal-
ing of colon anastomosis, using histomorphometric
and fractal parameters of the colonic wall, which are
objective and quantifiable. Additionally, bacterial flo-
ra growth at the site of anastomosis and skin wound
was examined. To the best of our knowledge, this is
one of the very few studies that have incorporated
histomorphometric parameters and fractal dimen-




The study was performed on 60 male Wistar rats
weighing 250–350 grams. In an effort to minimize
deaths following surgery, animals were brought to the
laboratory seven days before the start of the experi-
ment for adaptation, and to reduce the stress related
to transportation. The animals were acclimatized and
housed under standard conditions, three to a cage.
They were allowed standard rat chow and water ad
libitum throughout the study.
The study protocol was approved by the Bioethics
Committee of the Medical University of Lublin.
Operating procedure and treatment regimes
Before the surgery, the animals underwent general
anesthesia with nembutal, administered intraperito-
neally in a dosage of 50 mg per kilogram body weight.
After skin disinfection, a 3 cm skin and peritoneum
fragment was removed using surgical scissors. An
excision was performed rather than an incision in
order to extend the operative field and to avoid the
use of retractors that would additionally traumatize
the edges of the wound. The ascending colon was
exposed and incised just above the cecum in order
to allow an easy identification of the anastomosis
area after the surgery. The side to side enteroanas-
tomosis was created using interrupting inverting 5.0
polyglactin sutures. The peritoneum was closed us-
ing a continuous absorbable polyglactin 3.0 surgical
suture. Closing of the skin incision was performed
using interrupted nonabsorbable nylon 5.0 sutures.
The animals were then placed in cages for 30 minu-
tes and warmed up. Just after the surgery, the ani-
mals were allowed only water with 5% glucose (1:1
ratio) and solid food was introduced on the second
post-operative day. Antibiotic prophylaxis was not
applied.
After the surgery, animals were randomly as-
signed to one of four groups. Animals in the control
group (‘Group 1’) were injected with an isotonic salt
solution. Animals in the three remaining groups were
injected with 5-fluorouracil (20 mg/kg/day) (‘Group
2’), interferon-a (45.000 IU/kg/day) (‘Group 3’) and
dexamethasone (0.5 mg/day) (‘Group 4’). All the
substances were administered for five days, starting
from the second post-operative day, via intraperito-
neal injections. The injections were performed by
a single researcher at the same time of day through-
out the study.
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The rats were sacrificed using an intraperitoneal in-
jection of thiopental and dissected on either the
fourth, seventh or fourteenth day after surgery. Be-
fore each dissection, macroscopic evaluation of the
scar was performed. Samples for microbiological exa-
mination were collected from the skin wounds and
anastomosis sites of animals which presented with the
signs of commencing or ongoing infection. Reopen-
ing of the post-operative wound was made with steri-
le scissors, and the enteroanastomosis area was exa-
mined, taking particular care to maintain the sterility
of the area. Initially, the anastomosis was evaluated
macroscopically for the presence of dehiscence, ab-
scesses, adhesions, fistulae and symptoms of perito-
nitis. A scale used previously by Van der Ham in
a similar study was applied for that evaluation [27].
According to that scale, zero adhesions between
anastomosis and the surrounding structures were grad-
ed 0; minimal adhesions between anastomosis and
greater omentum were graded 1; larger adhesions be-
tween anastomosis and greater omentum and between
the anastomised parts and the small intestine loop
were graded 2; and large adhesions and abscesses
around the anastomosis were graded 3.
Areas suspected of having infection were sampled
for microbiological examination and cultures were
immediately set on a standard medium. After macro-
scopic inspection, a 3 cm fragment of the colon with
anastomosis site was resected and the leak-tightness
of the anastomosis was evaluated. Afterwards, a frag-
ment of tissue containing anastomosis was incubated
in a 4% formaldehyde solution. After being embed-
ded in paraffin, specimens were cut in a microtome
(Microm HM 360) into 5 mm sections. Twenty sections
were obtained from each specimen (at 20 mm intervals
after each series of five sections). Staining with hema-
toxylin and eosin was performed afterwards. Micro-
scopic images were obtained using a Nikon Eclipse
E800-light microscope and a Nikon D70 digital cam-
era, and underwent computerized planimetric analy-
sis using ImageJ® v. 1.37a, an image processing and
analysis software. The following parameters were con-
sidered in the evaluation: total crypt number per milli-
meter, active crypt number per millimeter, inactive
crypt number per millimeter, mucosa thickness, sub-
mucosa thickness, myenteron thickness, mucosa frac-
tal dimension (according to the box-counting method)
and connective tissue fractal dimension (using a UV
microscope). White blood cells count was also evalu-
ated in tail vein blood samples obtained on the fourth,
seventh and fourteenth post-operative days.
Statistical analysis
Continuous variables were presented as mean values
with standard deviation and 95% confidence inter-
val. Differences between the groups were evaluated
using one-way analysis of variance (ANOVA), Dun-
can’s multiple comparison test, and nonparametric
Mann–Whitney U test. P values of < 0.05 were con-
sidered to be significant. The statistical analysis was
performed using Microsoft Statistica 6.0 software.
The results of a comparative analysis are presen-
ted on boxplot graphs representing mean value, stan-
dard error of the mean (boxes) and confidence inter-
val of the mean (whiskers).
Results
Four animals (two from the dexamethasone group and
two from the interferon group) died after the surgery.
Macroscopic evaluation of the abdominal cavity per-
formed during the post mortem section did not re-
veal any significant deviations. Neither symptoms of
peritonitis, post-operative adhesions nor abscesses
were observed. Therefore it was assumed that the
death of the animals was the result either of the medi-
cine used to induce anesthesia or stress connected
with surgical intervention. The four animals were ex-
cluded from further analysis.
Macroscopic evaluation
Macroscopic inspection of the anastomosis and the
post-operative skin wound revealed the presence of
an inflammatory process in 32 rats. Nevertheless, neit-
her a perforation, nor an intra-abdominal abscess nor
an anastomosis rupture was observed in any of the
groups. Evaluation of the leak-tightness of the anas-
tomoses demonstrated leakage in three of the cases
treated with dexamethasone. This occurred on the
seventh post-operative day. No leaks were present in
other study groups.
The average adhesion formations on the fourth,
seventh and fourteenth post-operative days are pre-
sented in Table 1. Adhesion formation average scores
differed between the groups on the fourth post-oper-
ative day, and were highest in the interferon group.
Histomorphometric evaluation
Changes in the histomorphometric parameters were
observed in both the control and the treated groups.
But more intense alterations were seen in the treated
groups.
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Analysis of the histomorphometric parameters
performed in samples collected on the fourth post-
-operative day revealed a significant decrease in sub-
mucosal thickness (Figure 1) and an increase in in-
active crypt number in all treated animals. The lat-
ter parameter was highest in the 5-fluorouracil
group and was accompanied by increased mucosal
and myenteron thickness compared to the control
group. On the seventh post-operative day, a further
reduction in the submucosal diameter was observed
in the 5-fluorouracil group. Increases in active, and
decreases in inactive, crypt numbers were observed
in those animals treated with dexamethasone and
5-fluorouracil on that day also. Additionally, frac-
tal dimension of the connective tissue was reduced
in the interferon-treated and the dexamethasone-
treated groups (Figure 2), whereas the mucosa frac-
tal dimension was increased in those groups (Figu-
re 3). On the fourteenth post-operative day, signif-
icant decreases of submucosa and myenteron thick-
nesses, as well as reduced mucosa fractal dimension,
were present in all groups compared to controls
(Figures 4A–C).
The highest reduction of myenteron thickness was
observed in the interferon-treated animals, as was the
fractal dimension of the mucous membrane. The
greatest reduction of submucosa thickness was in the
group treated with 5-fluorouracil.
When the parameters were compared within the
groups according to time, it was found that a decrease
of almost all studied morphometric parameters oc-
curred on the seventh post-operative day in the con-
trols. Thereafter, on the fourteenth day after surgery,
the parameters regained values similar to those ob-
served on the fourth day. Values of the morphometric
parameters obtained on fourth, seventh and fourteenth
day of the experiment in the group treated with dex-
amethasone were not significantly different. A diffe-
rent sequel was observed in the groups treated with in-
terferon and 5-fluorouracil, in which particular param-
eters decreased progressively. A progressive decrease
of mucosa, submucosa and myenteron thickness was
observed in the 5-fluorouracil group (Figures 5A–C),
whereas the interferon group witnessed a progressive
Table 1. Average adhesion formations on the fourth,
seventh and fourteenth post-operative days
Day Control 5-fluorouracil Interferon Dexamethasone
of
experiment
4th 1 2 3 2.5
7th 1 1 2 1.3
14th 1 1 1.5 1
Figure 1. Thickness of submucosa on the fourth post-
operative day. Numbers above boxplots indicate statistical-
ly significant differences (p < 0.05): 1. vs. control group;
2. vs. interferon group; 3. vs. dexamethasone group;
4. vs. 5-fluorouracil group
Figure 2. Fractal dimensions of connective tissue of large
intestine on seventh (white boxes) and fourteenth (grey
boxes) post-operative days. Numbers above boxplots
indicate statistically significant differences (p < 0.05): 1. vs.
control group; 2. vs. interferon group; 3. vs. dexamethasone
group; 4. vs. 5-fluorouracil group
Figure 3. Fractal dimensions of mucosa of large intestine
on the seventh post-operative day. Numbers above box-
plots indicate statistically significant differences (p < 0.05):
1. vs. control group; 2. vs. interferon group; 3. vs. dexame-
thasone group; 4. vs. 5-fluorouracil group
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Figure 4. Parameters measured on fourteenth post-
operative day: A. myenteron thickness; B. submucosa
thickness; C. fractal dimension of mucosa. Numbers above
boxplots indicate statistically significant differences
(p < 0.05): 1. vs. control group; 2. vs. interferon group;
3. vs. dexamethasone group; 4. vs. 5-fluorouracil group
A B
C
Figure 5. Changes of parameters on fourth, seventh and
fourteenth post-operative day in the 5-fluorouracil group:
A. thickness of mucosa; B. thickness of submucosa;
C. myenteron thickness. Letters above boxplots indicate
statistically significant differences (p < 0.05): a. vs. fourth
post-operative day; b. vs. seventh post-operative day;
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reduction of mucosa (Figure 6A) and myenteron thick-
ness (Figure 6B), as well as mucosa fractal dimension.
At the same time, inactive crypt number gradually in-
creased in interferon-treated animals.
Connective tissue fractal dimension changes
Connective tissue fractal dimension was significantly
impaired in the interferon group on the seventh post-
-operative day compared to controls; it was also re-
duced on the fourteenth post-operative day in ani-
mals treated with dexamethasone (Figure 2). Addi-
tional analysis revealed that in animals treated with
interferon, it was significantly increased on the four-
teenth compared to the fourth post-operative day. No
other statistically relevant differences were encoun-
tered regarding that parameter.
Microbiological cultures
Collection of specimens for microbiological exami-
nation was performed in 32 animals, which presen-
ted symptoms of intraperitoneal or skin wound infec-
tion. On the fourth post-operative day, samples were
collected from eight animals, two in each group. On
the seventh day, a group of 14 animals qualified for
microbiological examination, six of which belonged
to the dexamethasone group, four to the interferon
group, and two each to the 5-fluorouracil and control
groups. Of the ten animals diagnosed with infection
on the fourteenth post-operative day, four belonged
to the control group, and two to each of the pharma-
cologically managed groups.
Bacterial growth was observed exclusively in sam-
ples collected on the fourth post-operative day from
the treated animals. Specimens obtained from the
control group did not reveal the presence of any
pathogens. The highest variety of pathogens was ob-
served in the interferon group. Microbiological cul-
ture results are presented in Table 2.
White blood cell count (WBC) evaluation
The lowest WBC was observed in the 5-fluorouracil
group on the seventh post-operative day, and the high-
est number of white blood cells occurred in the dexa-
methasone-treated animals on the fourteenth post-
operative day. Lymphocytosis (80–90%) was present
in all experimental animals, and was highest in the
control group on the fourteenth post-operative day.
Discussion
For many years, 5-fluorouracil has been used in adju-
vant therapy of colorectal cancer, and it is still conside-
red the gold standard in the post-operative manage-
ment of this neoplasm [1, 8]. The utility of interferons
has been also demonstrated for the treatment of colon
carcinoma in a number of studies, as agents that can
be administered alone or in combination with chemo-
therapeutics [9, 28, 29]. Dexamethasone was incorpo-
rated in our study protocol because steroids are com-
monly used in the post-operative management of pa-
tients undergoing bowel resection due to inflammato-
ry bowel diseases [2, 3]. The immediate or very early
implementation of adjuvant treatment is much more
efficacious in terms of survival rates and metastases
prevention compared to delayed chemotherapy.
However, it is commonly withheld until the wound
healing process is completed in order to prevent post-
A B
Figure 6. Changes of parameters on fourth, seventh and fourteenth post-operative days in the interferon group: A. thickness
of mucosa; B. myenteron thickness. Letters above boxplots indicate statistically significant differences (p < 0.05): a. vs.
fourth post-operative day; b. vs. seventh post-operative day; c. vs. fourteenth post-operative day
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-operative complications, which have been shown to
worsen patients’ prognosis in colorectal cancer [12,
15, 16]. Several studies have evaluated the effects of
different chemotherapeutics on anastomosis healing.
The methodology used in most of those studies re-
lied on the analysis of the macroscopic status of the
anastomosis. Additionally, bursting strength, intensi-
ty of local inflammation, and collagen content have
been used by some authors [25, 26]. The results of
those studies are not completely concordant.
In our study, we used histomorphometric and frac-
tal parameters. In addition, microbiological tests were
performed.
Histomorphometric analysis enables objective and
quantifiable assessment of the organs’ structure [30].
Fractal dimension is a parameter which reflects the
complexity and irregularity of studied organs [31].
Tissues undergoing remodeling or modification due
to exogenous or endogenous factors are characteri-
zed by an increased fractal dimension. Morphomet-
ric parameters and fractal geometry have been used
to distinguish benign from malignant lesions, to mea-
sure tumor infiltrative margins, to assess angiogene-
sis and distribution of collagen in tissues. Therefore
we considered them to be useful tools for evaluating
the enteroanastomosis healing process [32–34].
A combination of a reliable experimental model
and a method of analysis that enables objectivity and
provides high accuracy and uniformity in interpreting
the results might shed fresh light on the structural
changes responsible for the functional impairment of
the anastomosis.
Analysis of the morphometric changes that oc-
curred in the control group indicated that the sur-
gery itself evoked remodeling of the tissue within the
anastomosis; in particular, submucosa thickness and
the number of active and inactive crypts were reduced.
These results align with the study by Simmy et al. who
observed alterations in the enterocyte population,
crypt cell migration and the length of intestine villi as
effects of surgical intestine manipulation [35]. Neve-
rtheless, the alterations of morphometric parame-
ters observed in our study were much more signifi-
cant in the groups submitted to pharmacological treat-
ment. Administration of 5-fluorouracil and interfe-
ron evoked a progressive decrease of the mucosal,
submucosal, and myenteric thicknesses, plus a signifi-
cant reduction of the mucosa fractal dimension. Treat-
ment with dexamethasone was also connected with
a marked reduction in the submucosal and myen-
teric thicknesses, as well as with the decreased mu-
cosa fractal dimension that occurred on the fourteenth
post-operative day. A similar negative influence was
observed by Kanellos et al., whose histological exam-
ination of the anastomoses influenced by 5-fluorou-
racil treatment revealed an increased rupture rate as
well as necrosis and inflammation [36]. Conversely
to our results, they did not find interferon to exert
any negative effects on the healing process. In fact,
on the contrary, treatment with that immunomodu-
lator was connected with increased fibroblast prolif-
eration and collagen synthesis, whereas in our study
interferon administration resulted in a significant
decrease in the connective tissue fractal dimension,
a feature that reflected restoration of the connective
tissue structure [36].
Results which seemed to confirm our observation
were, however, obtained by Fu et al., who observed
impairment of skin wound healing and decreased
deposition of new collagen in a rat model of incised
skin wound [37]. Deterioration of the morphometric
features which was caused by 5-fluorouracil and in-
terferon did not correlate with increased frequency
of the anastomotic leakage in our study, which was
consistent with the results obtained by Hillan et al.
[38]. However, anastomotic leakage occurred in three
animals treated with dexamethasone.
The adverse effects of 5-fluorouracil on the heal-
ing of colon anastomosis have also been confirmed
by other authors. Ersoy et al. compared the influence
Table 2. Microbiological culture results in study groups on the fourth post-operative day
No. Group Enteroanastomosis culture Skin wound culture
1 5-fluorouracil Escherichia coli, Proteus species None
2 5-fluorouracil Escherichia coli, MRSA None
3 Interferon Escherichia coli, Proteus species, MRSA Escherichia coli
4 Interferon Escherichia coli, MRSA MRSA, Pseudomonas aeruginosa
5 Dexamethasone Escherichia coli Escherichia coli
6 Dexamethasone None MRSA
7 Control None None
8 Control None None
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of 5-fluorouracil and oxaliplatin on the colon anasto-
mosis healing process using the bursting pressure pro-
tocol with the assessment of hydroxyproline content
in the site of anastomosis. They found 5-fluorouracil
to negatively influence anastomosis status and to ex-
ert significantly more detrimental effects compared
to oxaliplatin. In concordance with our results, Ersoy
et al. did not find any significant influence of 5-fluo-
rouracil on the connective tissue remodeling reflec-
ted as collagen content changes [39]. The detrimen-
tal effects of 5-fluorouracil have also been demon-
strated by other researchers [26, 40, 41]. In the study
by Graf et al., it was found to significantly impair anas-
tomosis healing [40]. Another study (by the same re-
search group) revealed detrimental effects of 5-fluo-
rouracil on collagen synthesis, which was evident on
the seventh day after formation of anastomosis [41].
Weiber et al. investigated the relation between the
timing of 5-fluorouracil treatment introduction and
anastomosis status. Their results showed that delayed
treatment resulted in an uncomplicated healing pro-
cess, whereas beginning the regime on the day of sur-
gery was connected with detrimental effects on anas-
tomosis status [42]. Similar observations were ob-
tained in the studies by Kanellos et al. who compared
early and delayed combined treatment with 5-fluo-
rouracil and interferon or folinic acid [43, 44].
In the studies performed by Weiber at al. and
Kanellos et al., delayed therapy cycles begun on the
third and fourth days after surgery, respectively, were
connected with significantly less detrimental influence
on the healing process. Early treatment was intro-
duced on the day of surgery in those studies and re-
sulted in visible impairment of the anastomosis sta-
tus [42, 44]. In our study, treatment began on the se-
cond post-operative day. That could explain why mor-
phometric changes observed in 5-fluorouracil-treated
animals did not correlate with macroscopically visi-
ble impairment of the anastomosis.
Although many studies have shown the negative
effects of 5-fluorouracil on the healing of colon anas-
tomosis, the literature concerning that issue is not
entirely consistent. Contrary to the aforementioned
studies, Nayci et al. did not reveal impaired anasto-
mosis healing during treatment with 5-fluorouracil
[45]. Similar results were also obtained by Stoop et
al., who did not observe any influence of such treat-
ment on a bursting pressure of anastomosis [46]. No
bursting pressure alterations were present in a study
performed by el-Malt et al. either. However, similar-
ly to our observation, the authors reported the prese-
nce of histological changes at the anastomotic site in
the groups treated with 5-fluorouracil [47]. A study
performed by Kuzu et al. investigated the influence
of 5-fluorouracil administered before surgery and did
not observe any differences in the anastomosis heal-
ing between treated and control groups [48]. The only
alteration found in that study was a significant de-
crease in the hydroxyproline content within the anas-
tomoses of the treated animals [48].
A number of studies have shown steroids to exert
detrimental effects on the wound healing process.
Deterioration of the healing process evoked by ste-
roids is based on several mechanisms, including inhi-
bition of the local inflammatory response, inadequate
formation of granulation tissue, and improper me-
tabolism of the connective tissue which results from
the impairment of the collagen synthesis and the pro-
liferation of fibroblasts [21, 22, 49]. Our study shows
concordant results, as dexamethasone analyzed in our
study exerted significant adverse morphometric
changes, the most significant being submucosal and
myenteric thickness decreases, as well as reduction
of mucosa fractal dimension.
Moreover, macroscopic evaluation revealed leak-
age of the anastomosis in three animals treated with
that steroid. Similar results were obtained by Polat et
al. and Mantzoros et al., who found not only dexame-
thasone but also hydrocortisone perioperative treat-
ment to impair anastomosis wound healing [50, 51].
Additionally, Mantzoros et al. observed a correlation
between steroid treatment and a decreased deposi-
tion of collagen in the anastomotic site [51]. That
observation was consistent with our findings, as sig-
nificantly decreased fractal dimension of the connec-
tive tissue was observed in the dexamethasone group
on the fourteenth post-operative day. Similar results
were also obtained by Eubanks et al., who compared
the influence of methyloprednisolone, hydrocortisone
and dexamethasone on the colon wound healing pro-
cess [52]. They did not reveal differences in bursting
pressures between studied steroids, but the rate of
spontaneous ruptures was significantly higher in the
dexamethasone-treated animals [52].
The microbiological characteristics of the anasto-
motic site have been investigated in only a few stu-
dies. Kanellos et al. observed the growth of patholog-
ical flora in cases of peritonitis or abscess in animals
treated with 5-fluorouracil, or a combination of 5-fluo-
rouracil and interferon, as well as in one animal from
the control group. At the same time, the number of
animals affected by the pathogenic flora growth was
similar in both groups submitted to chemotherapy
(seven vs. eight animals) [25]. Concordant results were
obtained in our study. The same number of animals
from each study group presented with positive mi-
crobiological culture, although bacterial spectrum
differed.
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The microbiological examination performed by
Kanellos et al. revealed the presence of Escherichia
coli, Enterococcus, Proteus and Bacteroides spp. [25].
Our study discovered Escherichia coli and Proteus spp.
but also methiciline-resistant Staphylococcus aureus
sp. in animals treated with 5-fluorouracil and inter-
feron. Treatment with dexamethasone was connec-
ted with the presence of Escherichia coli spp. and re-
sulted in leakage of the anastomosis in two of three
infected animals. Contrary to the results obtained by
Kanellos, no pathogens were cultured in the speci-
mens obtained from the control group in our study.
Conclusions
All three pharmaceutical agents analyzed in our study
impaired healing of the anastomoses and promoted
infection in the anastomosis and skin wound sites.
Dexamethasone induced both morphometric and
macroscopic alterations. Therefore, it was considered
the most detrimental in our study. Our results con-
cord with most previous studies, which used macro-
scopic characteristics and bursting strength to assess
the anastomosis healing process.
Therefore, histomorphometric and fractal parame-
ters seem to be useful and valid tools for use in such
an experimental setting.
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